Trial Profile
Determination of the fracture probability and quality of life using FRAX in Japanese postmenopausal women receiving raloxifene for osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2014
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 22 Apr 2014 New trial record